Cargando…
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234990/ https://www.ncbi.nlm.nih.gov/pubmed/32424154 http://dx.doi.org/10.1038/s41408-020-0326-1 |
| _version_ | 1783535879936016384 |
|---|---|
| author | Mina, Roberto Belotti, Angelo Petrucci, Maria Teresa Zambello, Renato Capra, Andrea Di Lullo, Giacomo Ronconi, Sonia Pescosta, Norbert Grasso, Mariella Monaco, Federico Cellini, Claudia Gobbi, Marco Ballanti, Stelvio de Fabritiis, Paolo Mosca-Siez, Maria Letizia Marchetti, Monia Liberati, Anna Marina Offidani, Massimo Giuliani, Nicola Ria, Roberto Musto, Pellegrino Romano, Alessandra Sonneveld, Pieter Boccadoro, Mario Larocca, Alessandra |
| author_facet | Mina, Roberto Belotti, Angelo Petrucci, Maria Teresa Zambello, Renato Capra, Andrea Di Lullo, Giacomo Ronconi, Sonia Pescosta, Norbert Grasso, Mariella Monaco, Federico Cellini, Claudia Gobbi, Marco Ballanti, Stelvio de Fabritiis, Paolo Mosca-Siez, Maria Letizia Marchetti, Monia Liberati, Anna Marina Offidani, Massimo Giuliani, Nicola Ria, Roberto Musto, Pellegrino Romano, Alessandra Sonneveld, Pieter Boccadoro, Mario Larocca, Alessandra |
| author_sort | Mina, Roberto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7234990 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72349902020-05-20 Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study Mina, Roberto Belotti, Angelo Petrucci, Maria Teresa Zambello, Renato Capra, Andrea Di Lullo, Giacomo Ronconi, Sonia Pescosta, Norbert Grasso, Mariella Monaco, Federico Cellini, Claudia Gobbi, Marco Ballanti, Stelvio de Fabritiis, Paolo Mosca-Siez, Maria Letizia Marchetti, Monia Liberati, Anna Marina Offidani, Massimo Giuliani, Nicola Ria, Roberto Musto, Pellegrino Romano, Alessandra Sonneveld, Pieter Boccadoro, Mario Larocca, Alessandra Blood Cancer J Correspondence Nature Publishing Group UK 2020-05-18 /pmc/articles/PMC7234990/ /pubmed/32424154 http://dx.doi.org/10.1038/s41408-020-0326-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Mina, Roberto Belotti, Angelo Petrucci, Maria Teresa Zambello, Renato Capra, Andrea Di Lullo, Giacomo Ronconi, Sonia Pescosta, Norbert Grasso, Mariella Monaco, Federico Cellini, Claudia Gobbi, Marco Ballanti, Stelvio de Fabritiis, Paolo Mosca-Siez, Maria Letizia Marchetti, Monia Liberati, Anna Marina Offidani, Massimo Giuliani, Nicola Ria, Roberto Musto, Pellegrino Romano, Alessandra Sonneveld, Pieter Boccadoro, Mario Larocca, Alessandra Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study |
| title | Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study |
| title_full | Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study |
| title_fullStr | Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study |
| title_full_unstemmed | Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study |
| title_short | Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study |
| title_sort | bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase ii study |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234990/ https://www.ncbi.nlm.nih.gov/pubmed/32424154 http://dx.doi.org/10.1038/s41408-020-0326-1 |
| work_keys_str_mv | AT minaroberto bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT belottiangelo bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT petruccimariateresa bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT zambellorenato bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT capraandrea bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT dilullogiacomo bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT ronconisonia bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT pescostanorbert bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT grassomariella bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT monacofederico bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT celliniclaudia bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT gobbimarco bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT ballantistelvio bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT defabritiispaolo bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT moscasiezmarialetizia bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT marchettimonia bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT liberatiannamarina bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT offidanimassimo bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT giulianinicola bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT riaroberto bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT mustopellegrino bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT romanoalessandra bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT sonneveldpieter bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT boccadoromario bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy AT laroccaalessandra bortezomibdexamethasoneasmaintenancetherapyorearlyretreatmentatbiochemicalrelapseversusobservationinrelapsedrefractorymultiplemyelomapatientsarandomizedphaseiistudy |